Corporate long end premiums rise, short end dips to negative

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Corporate long end premiums rise, short end dips to negative

biopharma_stocks_adobe_575x375.jpg
Healthcare medical biopharmaceutical investing stock chart background | Kurhan - stock.adobe.com

Europe’s corporate bond investors preferred shorter deals on Tuesday. Issuers seeking maturities past five years had to pay double-digit new issue premiums, while short notes got negative concessions.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article